Detalhe da pesquisa
1.
FDA Public Workshop Summary-Addressing Challenges in Inhaled Antifungal Drug Development.
Clin Infect Dis
; 2023 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37802928
2.
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.
N Engl J Med
; 372(3): 211-21, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25415805
3.
Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
Kidney Int
; 90(3): 696-704, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27350174
4.
Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia.
Kidney Int
; 88(6): 1427-1433, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26376130
5.
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.
JAMA
; 314(2): 151-61, 2015 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26172895
6.
Endocrine profile of the kisspeptin receptor agonist MVT-602 in healthy premenopausal women with and without ovarian stimulation: results from 2 randomized, placebo-controlled clinical tricals.
Fertil Steril
; 121(1): 95-106, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37925096
7.
Correction to: Novel Approaches Towards a Functional Cure of HIV/AIDS.
Drugs
; 80(9): 869, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32495275
8.
Novel Approaches Towards a Functional Cure of HIV/AIDS.
Drugs
; 80(9): 859-868, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436069
9.
Are high-risk hypertensive patients being prescribed concomitant statin therapy?: a retrospective cohort study.
Am J Cardiovasc Drugs
; 9(5): 299-308, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19791839
10.
Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers: results from AMETHYST-DN.
ESC Heart Fail
; 5(4): 592-602, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29767459
11.
Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease.
ESC Heart Fail
; 5(3): 257-266, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29369537
12.
Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics.
J Hypertens
; 35 Suppl 1: S57-S63, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28129247
13.
Mechanism of Action and Pharmacology of Patiromer, a Nonabsorbed Cross-Linked Polymer That Lowers Serum Potassium Concentration in Patients With Hyperkalemia.
J Cardiovasc Pharmacol Ther
; 21(5): 456-65, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26856345
14.
New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval.
Int J Cardiol
; 216: 46-51, 2016 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27140336
15.
Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors.
Eur J Heart Fail
; 17(10): 1057-65, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26459796
16.
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.
JAMA
; 292(18): 2217-25, 2004 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15536108